appears presentation was held on 15th in the US and shares remained flat with no change in price. I guess its either presented after market or its same news. I like their thinking about using drug in first line therapy based on earlier trials as a last resort drug. The lack of share reaction makes me wonder if another company is more advanced with competing drugs?, anyone shine any info on this
- Forums
- ASX - By Stock
- KZA
- Ann: Kazia presents to H C Wainwright conference
Ann: Kazia presents to H C Wainwright conference, page-7
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)